United Pharm

United Pharm

033270 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

15,590.00KRW-90.00 (-0.57%)

Price History

Full chart

Market Stats

Previous Close15,680.00
Open15,750.00
Day Range15,540.00 – 15,810.00
52-Week Range16,100.00 – 21,800.00
Volume21.69K
Market Cap279.94B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield3.44%
Beta0.31
50-Day Avg17,946.20
200-Day Avg18,891.15

About

Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC drugs. The company also exports its products to approximately 40 countries. Korea United Pharm Inc. was founded in 1987 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Duk-Young Kang
  • Employees0
  • HeadquartersNonhyeon-ro 121street 22, Seoul, South Korea, Korea
  • Websitehttps://www.kup.co.kr

Leadership

  • Mr. Duk-Young KangChief Executive Officer · b. 1947

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue145.45B134.83B136.89B155.19B176.91B197.02B211.94B221.31B215.95B221.04B262.52B278.94B288.71B288.76B
Growth (%)--7.30%+1.53%+13.37%+13.99%+11.37%+7.57%+4.42%-2.42%+2.36%+18.77%+6.26%+3.50%+0.02%
Cost of Revenue59.47B62.39B67.23B74.20B80.08B85.16B86.46B92.72B90.76B98.38B117.23B119.97B124.74B128.17B
Gross Profit85.99B72.44B69.66B80.99B96.83B111.86B125.48B128.59B125.19B122.66B145.29B158.98B163.97B160.60B
Gross Margin59.12%53.72%50.89%52.19%54.74%56.78%59.21%58.10%57.97%55.49%55.34%56.99%56.79%55.61%
Operating Expense58.96B52.93B54.83B58.50B69.71B80.14B87.73B93.59B85.07B89.43B97.07B103.70B130.45B110.48B
Operating Income27.03B19.51B14.84B22.49B27.12B31.72B37.75B35.00B40.13B33.23B48.21B55.27B33.52B50.11B
Operating Margin18.58%14.47%10.84%14.49%15.33%16.10%17.81%15.81%18.58%15.03%18.37%19.82%11.61%17.35%
EBITDA-----36.39B47.88B46.51B44.72B47.66B63.23B71.80B57.84B61.55B
EBITDA Margin-----18.47%22.59%21.01%20.71%21.56%24.09%25.74%20.04%21.32%
Net Income20.21B16.38B12.21B18.37B19.51B27.86B31.67B30.92B26.61B28.65B45.28B48.26B32.45B38.31B
Net Income Margin13.89%12.15%8.92%11.84%11.03%14.14%14.94%13.97%12.32%12.96%17.25%17.30%11.24%13.27%
R&D1.27B1.30B3.00B3.99B4.01B4.90B12.44B14.10B12.27B13.79B15.54B17.30B16.21B17.86B
R&D as % of Total Revenue0.87%0.96%2.20%2.57%2.26%2.49%5.87%6.37%5.68%6.24%5.92%6.20%5.62%6.19%
Interest Expense000000605.38M702.29M575.54M501.92M815.54M1.62B484.41M173.58M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.29%0.32%0.27%0.23%0.31%0.58%0.17%0.06%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets170.09B187.58B193.54B217.10B234.22B265.80B301.95B331.24B353.43B380.03B417.89B468.86B473.93B519.49B
Total Liabilities57.04B54.10B52.10B55.27B56.83B64.11B73.47B76.14B76.54B79.32B80.03B90.18B67.72B64.86B
Total Equity113.03B133.47B141.43B161.83B177.39B201.68B228.48B255.10B276.89B300.71B337.86B378.68B406.21B454.63B
Cash18.00B16.82B26.44B31.12B18.39B10.01B24.31B40.00B40.48B60.83B26.90B23.91B33.70B40.29B
Net Debt-----15.17B4.23B---2.40B15.49B--

Cash Flow

Currency: KRW2011-12-312012-12-312013-12-312014-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow27.62B21.88B18.97B21.31B30.02B27.68B36.86B38.15B36.96B44.09B63.78B49.77B26.79B51.14B
Investing Cash Flow-17.42B-23.33B-4.95B-20.08B----------
Financing Cash Flow353.03M314.24M-4.20B3.35B----------
Capital Expenditure14.95B12.16B12.11B8.05B13.29B27.59B17.35B19.76B12.55B12.79B24.21B31.31B21.22B25.14B
Free Cash Flow-----90.81M19.52B18.40B24.42B31.30B39.57B18.46B5.57B25.99B
Dividends Paid1.46B1.63B1.86B759.25M3.39B3.70B4.44B4.89B4.89B5.20B5.49B5.88B6.14B6.62B
FCF to OCF-----0.33%52.95%48.21%66.06%70.99%62.05%37.09%20.80%50.83%
Dividend Paid to FCF-----4076.03%22.76%26.56%20.04%16.60%13.88%31.87%110.22%25.47%

Earnings

Report DateMar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Oct 30, 2014Feb 27, 2015Apr 28, 2015Jul 29, 2015Nov 3, 2015Mar 10, 2016May 3, 2016Jul 29, 2016Nov 1, 2016Mar 9, 2017Apr 28, 2017Jul 28, 2017Oct 29, 2017Feb 22, 2018Apr 27, 2018Jul 27, 2018Oct 26, 2018Mar 7, 2019Apr 25, 2019Jul 26, 2019Nov 13, 2019Mar 12, 2020Apr 28, 2020Jul 30, 2020Nov 13, 2020Mar 15, 2021May 14, 2021Jul 28, 2021Oct 29, 2021Mar 14, 2022Apr 29, 2022Jul 27, 2022Nov 1, 2022Mar 3, 2023May 12, 2023Aug 11, 2023Oct 31, 2023Mar 18, 2024May 14, 2024Jul 25, 2024Oct 31, 2024Mar 17, 2025Apr 29, 2025Jul 23, 2025Oct 29, 2025Dec 31, 2025Apr 27, 2026Jun 30, 2026
EPS Estimate-------------------------------311.00323.00------476.00540.00---------------------------------
EPS Actual182.01190.61153.3064.78361.72263.73206.4890.26210.73318.22335.91243.11410.33434.67408.33125.09388.47246.88233.61243.19257.26184.81139.09169.61341.73186.66334.48298.04395.85261.90314.65414.00456.00111.72285.98423.00330.92452.08721.26378.00575.00536.00492.00536.00627.00441.00605.60412.00787.00295.00532.00174.70614.87443.84727.36140.37767.35991.921618.38-324.48930.15975.731152.35176.961308.42-432.98356.15977.44860.3180.24923.43747.59875.982377.30
Surprise-------------------------------33.12%41.18%-------20.59%6.48%---------------------------------
Timing---------------------------Pre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap279.94B
Enterprise Value115.93B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales1.73
Price / Book0.56
Revenue (TTM)161.44B
Gross Profit (TTM)84.80B
EBITDA30.47B
Profit Margin12.40%
Operating Margin9.92%
Return on Equity12.21%
Return on Assets6.78%
Shares Outstanding15.86M
Shares Float8.43M
Beta0.31
Dividend Yield3.44%
Dividend Rate610.00
Payout Ratio12.39%

Dividends

20251×
610.00Dec 29, 2025
20241×
450.00Dec 27, 2024
20231×
420.00Dec 27, 2023
20221×
400.00Dec 28, 2022
20211×
370.00Dec 29, 2021
20201×
350.00Dec 29, 2020
20191×
330.00Dec 27, 2019
20181×
330.00Dec 27, 2018
20171×
300.00Dec 27, 2017
20161×
250.00Dec 28, 2016
20151×
220.00Dec 29, 2015
20141×
200.00Dec 29, 2014
20131×
49.02Dec 27, 2013
20121×
117.65Dec 27, 2012
20111×
107.84Dec 28, 2011
20101×
98.04Dec 29, 2010
20091×
73.53Dec 29, 2009
20081×
58.82Dec 29, 2008
20072×
49.02Dec 27, 200749.02Mar 29, 2007
20061×
49.02Mar 30, 2006
20051×
49.02Mar 30, 2005
20041×
49.02Mar 30, 2004
20031×
58.82Mar 28, 2003

Stock Splits

  • Jan 20, 20141.02:1
  • Feb 19, 200110:1